- Home
- RMTI vs XGN Comparison
RMTI vs XGN Comparison
Compare RMTI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- XGN
- Stock Information
- Founded
- RMTI 1994
- XGN 2002
- Country
- RMTI United States
- XGN United States
- Employees
- RMTI N/A
- XGN N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- XGN Medical Specialities
- Sector
- RMTI Health Care
- XGN Health Care
- Exchange
- RMTI Nasdaq
- XGN Nasdaq
- Market Cap
- RMTI 72.7M
- XGN 72.3M
- IPO Year
- RMTI 1998
- XGN 2019
- Fundamental
- Price
- RMTI $2.18
- XGN $4.04
- Analyst Decision
- RMTI Strong Buy
- XGN Strong Buy
- Analyst Count
- RMTI 2
- XGN 2
- Target Price
- RMTI $6.00
- XGN $7.50
- AVG Volume (30 Days)
- RMTI 309.2K
- XGN 201.2K
- Earning Date
- RMTI 11-12-2024
- XGN 03-17-2025
- Dividend Yield
- RMTI N/A
- XGN N/A
- EPS Growth
- RMTI N/A
- XGN N/A
- EPS
- RMTI N/A
- XGN N/A
- Revenue
- RMTI $98,917,000.00
- XGN $55,751,000.00
- Revenue This Year
- RMTI $22.58
- XGN $6.81
- Revenue Next Year
- RMTI N/A
- XGN $17.72
- P/E Ratio
- RMTI N/A
- XGN N/A
- Revenue Growth
- RMTI 22.37
- XGN 8.00
- 52 Week Low
- RMTI $1.16
- XGN $1.30
- 52 Week High
- RMTI $5.15
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- RMTI 49.23
- XGN 52.65
- Support Level
- RMTI $2.08
- XGN $2.76
- Resistance Level
- RMTI $2.41
- XGN $4.20
- Average True Range (ATR)
- RMTI 0.11
- XGN 0.48
- MACD
- RMTI 0.03
- XGN 0.04
- Stochastic Oscillator
- RMTI 47.73
- XGN 76.19
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.